 | • レポートコード：MRC23Q36447 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のウイルス養殖病治療市場について調査・分析し、世界のウイルス養殖病治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（不活化ウイルスワクチン、生ウイルスワクチン）、用途別セグメント分析（動物病院、動物病院、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Zoetis LLC(Pfizer Inc.)、Intervet Inc. (Merck & Co. Inc.)、Tecnovax SA、Virbac、Veterquimica SA、Nisseiken Co., Ltd.などが含まれています。世界のウイルス養殖病治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ウイルス養殖病治療市場規模を推定する際に考慮しました。本レポートは、ウイルス養殖病治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ウイルス養殖病治療に関するビジネス上の意思決定に役立てることを目的としています。 ・ウイルス養殖病治療市場の概要 - ウイルス養殖病治療のタイプ別セグメント - 世界のウイルス養殖病治療市場規模：タイプ別分析（不活化ウイルスワクチン、生ウイルスワクチン） - ウイルス養殖病治療の用途別セグメント - 世界のウイルス養殖病治療市場規模：用途別分析（動物病院、動物病院、その他） - 世界のウイルス養殖病治療市場規模予測（2018年-2029年） ・ウイルス養殖病治療市場の成長トレンド - ウイルス養殖病治療の地域別市場規模（2018年-2029年） - ウイルス養殖病治療市場ダイナミクス - ウイルス養殖病治療の業界動向 - ウイルス養殖病治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：不活化ウイルスワクチン、生ウイルスワクチン - 世界のウイルス養殖病治療のタイプ別市場規模（2018年-2023年） - 世界のウイルス養殖病治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：動物病院、動物病院、その他 - 世界のウイルス養殖病治療の用途別市場規模（2018年-2023年） - 世界のウイルス養殖病治療の用途別市場規模（2024年-2029年） ・ウイルス養殖病治療の地域別市場規模 - 北米のウイルス養殖病治療市場規模（2018年-2029年） - アメリカのウイルス養殖病治療市場規模（2018年-2029年） - ヨーロッパのウイルス養殖病治療市場規模（2018年-2029年） - アジア太平洋のウイルス養殖病治療市場規模（2018年-2029年） - 中国のウイルス養殖病治療市場規模（2018年-2029年） - 日本のウイルス養殖病治療市場規模（2018年-2029年） - 韓国のウイルス養殖病治療市場規模（2018年-2029年） - インドのウイルス養殖病治療市場規模（2018年-2029年） - オーストラリアのウイルス養殖病治療市場規模（2018年-2029年） - 中南米のウイルス養殖病治療市場規模（2018年-2029年） - 中東・アフリカのウイルス養殖病治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Zoetis LLC(Pfizer Inc.)、Intervet Inc. (Merck & Co. Inc.)、Tecnovax SA、Virbac、Veterquimica SA、Nisseiken Co., Ltd. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Viral Aquaculture Disease Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Viral Aquaculture Disease Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Viral Aquaculture Disease Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Viral Aquaculture Disease Treatment in Veterinary Clinic is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Viral Aquaculture Disease Treatment include Zoetis LLC(Pfizer Inc.), Intervet Inc. (Merck & Co. Inc.), Tecnovax SA, Virbac, Veterquimica SA and Nisseiken Co., Ltd., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Viral Aquaculture Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Aquaculture Disease Treatment.
The Viral Aquaculture Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Viral Aquaculture Disease Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Aquaculture Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Zoetis LLC(Pfizer Inc.)
Intervet Inc. (Merck & Co. Inc.)
Tecnovax SA
Virbac
Veterquimica SA
Nisseiken Co., Ltd.
Segment by Type
Inactivated Virus Vaccine
Live Virus Vaccine
Segment by Application
Veterinary Clinic
Veterinary Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Aquaculture Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Aquaculture Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Inactivated Virus Vaccine
1.2.3 Live Virus Vaccine
1.3 Market by Application
1.3.1 Global Viral Aquaculture Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Veterinary Clinic
1.3.3 Veterinary Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Aquaculture Disease Treatment Market Perspective (2018-2029)
2.2 Viral Aquaculture Disease Treatment Growth Trends by Region
2.2.1 Global Viral Aquaculture Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Viral Aquaculture Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Viral Aquaculture Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Viral Aquaculture Disease Treatment Market Dynamics
2.3.1 Viral Aquaculture Disease Treatment Industry Trends
2.3.2 Viral Aquaculture Disease Treatment Market Drivers
2.3.3 Viral Aquaculture Disease Treatment Market Challenges
2.3.4 Viral Aquaculture Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Aquaculture Disease Treatment Players by Revenue
3.1.1 Global Top Viral Aquaculture Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Viral Aquaculture Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Viral Aquaculture Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Aquaculture Disease Treatment Revenue
3.4 Global Viral Aquaculture Disease Treatment Market Concentration Ratio
3.4.1 Global Viral Aquaculture Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Aquaculture Disease Treatment Revenue in 2022
3.5 Viral Aquaculture Disease Treatment Key Players Head office and Area Served
3.6 Key Players Viral Aquaculture Disease Treatment Product Solution and Service
3.7 Date of Enter into Viral Aquaculture Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Aquaculture Disease Treatment Breakdown Data by Type
4.1 Global Viral Aquaculture Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Viral Aquaculture Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Viral Aquaculture Disease Treatment Breakdown Data by Application
5.1 Global Viral Aquaculture Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Viral Aquaculture Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Viral Aquaculture Disease Treatment Market Size (2018-2029)
6.2 North America Viral Aquaculture Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Viral Aquaculture Disease Treatment Market Size by Country (2018-2023)
6.4 North America Viral Aquaculture Disease Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Aquaculture Disease Treatment Market Size (2018-2029)
7.2 Europe Viral Aquaculture Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Viral Aquaculture Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Viral Aquaculture Disease Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Aquaculture Disease Treatment Market Size (2018-2029)
8.2 Asia-Pacific Viral Aquaculture Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Viral Aquaculture Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Viral Aquaculture Disease Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Aquaculture Disease Treatment Market Size (2018-2029)
9.2 Latin America Viral Aquaculture Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Viral Aquaculture Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Viral Aquaculture Disease Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Aquaculture Disease Treatment Market Size (2018-2029)
10.2 Middle East & Africa Viral Aquaculture Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Viral Aquaculture Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Viral Aquaculture Disease Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis LLC(Pfizer Inc.)
11.1.1 Zoetis LLC(Pfizer Inc.) Company Detail
11.1.2 Zoetis LLC(Pfizer Inc.) Business Overview
11.1.3 Zoetis LLC(Pfizer Inc.) Viral Aquaculture Disease Treatment Introduction
11.1.4 Zoetis LLC(Pfizer Inc.) Revenue in Viral Aquaculture Disease Treatment Business (2018-2023)
11.1.5 Zoetis LLC(Pfizer Inc.) Recent Development
11.2 Intervet Inc. (Merck & Co. Inc.)
11.2.1 Intervet Inc. (Merck & Co. Inc.) Company Detail
11.2.2 Intervet Inc. (Merck & Co. Inc.) Business Overview
11.2.3 Intervet Inc. (Merck & Co. Inc.) Viral Aquaculture Disease Treatment Introduction
11.2.4 Intervet Inc. (Merck & Co. Inc.) Revenue in Viral Aquaculture Disease Treatment Business (2018-2023)
11.2.5 Intervet Inc. (Merck & Co. Inc.) Recent Development
11.3 Tecnovax SA
11.3.1 Tecnovax SA Company Detail
11.3.2 Tecnovax SA Business Overview
11.3.3 Tecnovax SA Viral Aquaculture Disease Treatment Introduction
11.3.4 Tecnovax SA Revenue in Viral Aquaculture Disease Treatment Business (2018-2023)
11.3.5 Tecnovax SA Recent Development
11.4 Virbac
11.4.1 Virbac Company Detail
11.4.2 Virbac Business Overview
11.4.3 Virbac Viral Aquaculture Disease Treatment Introduction
11.4.4 Virbac Revenue in Viral Aquaculture Disease Treatment Business (2018-2023)
11.4.5 Virbac Recent Development
11.5 Veterquimica SA
11.5.1 Veterquimica SA Company Detail
11.5.2 Veterquimica SA Business Overview
11.5.3 Veterquimica SA Viral Aquaculture Disease Treatment Introduction
11.5.4 Veterquimica SA Revenue in Viral Aquaculture Disease Treatment Business (2018-2023)
11.5.5 Veterquimica SA Recent Development
11.6 Nisseiken Co., Ltd.
11.6.1 Nisseiken Co., Ltd. Company Detail
11.6.2 Nisseiken Co., Ltd. Business Overview
11.6.3 Nisseiken Co., Ltd. Viral Aquaculture Disease Treatment Introduction
11.6.4 Nisseiken Co., Ltd. Revenue in Viral Aquaculture Disease Treatment Business (2018-2023)
11.6.5 Nisseiken Co., Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details